This analog also inhibits the epithelial-mesenchymal transition of cancer cells, thereby preventing invasive growth and metastases of cancer cells [72], indicating that in addition to CB2-R, CB1-R is also a main target for the observed anticancer effect. This evidence concerns the gene CNR1 and cancer.